Treatment of Necrotizing Fasciitis with Documented Staphylococcus aureus
When necrotizing fasciitis occurs with a documented Staphylococcus aureus infection, identification of the causative pathogen directly shapes the treatment strategy. Pathogen-directed management can be applied from the outset.
Clinical Scenario
Staphylococcus aureus is one of the recognised pathogens in the monomicrobial form of necrotizing fasciitis. Once the microbial aetiology has been documented — for example through blood culture — antibiotic coverage is appropriately targeted to the identified organism.
Treatment Approach
Management requires surgical debridement combined with targeted antistaphylococcal antibiotic therapy. The selection of specific agents depends on susceptibility findings. The full structured protocol covers the complete agent options, selection criteria, and sequencing.
Treatment Goal
Clinical improvement and absence of fever for 48–72 hours.
References
DOI: 10.1093/cid/ciu296
In the monomicrobial form, the usual pathogens are S. pyogenes, S. aureus, V. vulnificus, A. hydrophila, and anaerobic streptococci (Peptostreptococcus).
Once the microbial etiology has been determined, the antibiotic coverage should be appropriately modified.
In the absence of definitive clinical trials, antimicrobial therapy should be administered until further debridement is no longer necessary, the patient has improved clinically, and fever has been absent for 48–72 hours.
View source ↗